Works by Czaja, Angela S.


Results: 13
    1
    2
    3
    4
    5

    Electronic health record (EHR) based postmarketing surveillance of adverse events associated with pediatric off‐label medication use: A case study of short‐acting beta‐2 agonists and arrhythmias.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 7, p. 815, doi. 10.1002/pds.4562
    By:
    • Czaja, Angela S.;
    • Ross, Michelle E.;
    • Liu, Weiwei;
    • Fiks, Alexander G.;
    • Localio, Russell;
    • Wasserman, Richard C.;
    • Grundmeier, Robert W.;
    • Adams, William G.;
    • for the Comparative Effectiveness Research through Collaborative Electronic Reporting (CER2) Consortium
    Publication type:
    Article
    6

    Current needs in pediatric pharmacoepidemiology.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 6, p. 738, doi. 10.1002/pds.3985
    By:
    • Lasky, Tamar;
    • Artaman, Al;
    • Czaja, Angela S.;
    • Maruti, Sonia S.;
    • Osokogu, Osemeke U.;
    • Verhamme, Katia M.C.;
    • Sobel, Rachel E.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Left ventricular dysfunction in Duchenne muscular dystrophy.

    Published in:
    2020
    By:
    • James, Katherine A.;
    • Gralla, Jane;
    • Ridall, Leslie A.;
    • Do, ThuyQuynh N.;
    • Czaja, Angela S.;
    • Mourani, Peter M.;
    • Ciafaloni, Emma;
    • Cunniff, Christopher;
    • Donnelly, Jennifer;
    • Oleszek, Joyce;
    • Pandya, Shree;
    • Price, Elinora;
    • Yang, Michele L.;
    • Auerbach, Scott R.
    Publication type:
    journal article
    13